A Phase I/II Study of the Protease Inhibitor Indinavir in Children With HIV Infection

Abstract

Indinavir dry-filled capsules are relatively well tolerated by children with HIV infection, although hematuria occurs at higher doses. Future studies need to evaluate the efficacy of indinavir when combined de novo with zidovudine and lamivudine.